ACA
JNJ icon

Atlas Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Atlas Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Buy
6,129
+360
+6% +$83.9K 0.17% 117
2025
Q4 		$1.19M Buy
+5,769
New +$1.14M 0.13% 131
2025
Q2 		$880K Hold
5,761
– – 0.11% 168
2025
Q1 		$955K Hold
5,761
– – 0.12% 149
2024
Q4 		$833K Buy
5,761
+5,700
+9,344% +$883K 0.11% 167
2024
Q3 		$9.88K Sell
61
-5,700
-99% -$908K ﹤0.01% 729
2024
Q2 		$842K Buy
5,761
+5,178
+888% +$770K 0.11% 147
2024
Q1 		$92.2K Sell
583
-5,478
-90% -$872K 0.01% 493
2023
Q4 		$950K Sell
6,061
-10
-0.2% -$1.53K 0.14% 128
2023
Q3 		$946K Hold
6,071
– – 0.16% 108
2023
Q2 		$1M Buy
6,071
+279
+5% +$45K 0.15% 109
2023
Q1 		$898K Hold
5,792
– – 0.14% 108
2022
Q4 		$1.02M Hold
5,792
– – 0.17% 104
2022
Q3 		$946K Sell
5,792
-729
-11% -$123K 0.17% 108
2022
Q2 		$1.16M Hold
6,521
– – 0.2% 97
2022
Q1 		$1.16M Hold
6,521
– – 0.18% 103
2021
Q4 		$1.12M Hold
6,521
– – 0.17% 103
2021
Q3 		$1.05M Sell
6,521
-300
-4% -$51.2K 0.17% 107
2021
Q2 		$1.12M Buy
6,821
+71
+1% +$11.8K 0.19% 108
2021
Q1 		$1.11M Sell
6,750
-50
-0.7% -$8.09K 0.22% 99
2020
Q4 		$1.07M Hold
6,800
– – 0.23% 92
2020
Q3 		$1.01M Sell
6,800
-46
-0.7% -$6.81K 0.24% 97
2020
Q2 		$963K Hold
6,846
– – 0.23% 98
2020
Q1 		$898K Buy
6,846
+1
+0% +$142 0.27% 89
2019
Q4 		$999K Sell
6,845
-958
-12% -$130K 0.25% 106
2019
Q3 		$1.01M Sell
7,803
-10,514
-57% -$1.39M 0.3% 95
2019
Q2 		$2.55M Buy
18,317
+2,784
+18% +$385K 0.84% 17
2019
Q1 		$2.17M Sell
15,533
-1,105
-7% -$148K 0.78% 24
2018
Q4 		$2.15M Buy
16,638
+10,638
+177% +$1.48M 0.86% 20
2018
Q3 		$834K Hold
6,000
– – 0.28% 97
2018
Q2 		$775K Sell
6,000
-523
-8% -$65.2K 0.28% 105
2018
Q1 		$836K Buy
+6,523
New +$882K 0.26% 114

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Atlas Capital Advisors's JNJ Position: Q1 2026 in Review

Atlas Capital Advisors increased its Johnson & Johnson (JNJ) stake by 6.2% in Q1 2026, buying an estimated $83.9K and bringing the position to 6,129 shares worth $1.5M. The position accounts for 0.17% of the portfolio, ranked #117.

Atlas Capital Advisors first reported a position in JNJ in Q1 2018 and has held it in 32 quarters since. The position peaked at $2.55M in Q2 2019. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Atlas Capital Advisors held 6,129 shares of Johnson & Johnson worth $1.5M as of Q1 2026.
  • Atlas Capital Advisors bought 360 Johnson & Johnson shares in Q1 2026, an estimated $83.9K.
  • Johnson & Johnson made up 0.17% of Atlas Capital Advisors's portfolio in Q1 2026, its #117 holding.
  • Atlas Capital Advisors first reported a position in Johnson & Johnson in Q1 2018 and has held it in 32 quarters since.
  • Atlas Capital Advisors's Johnson & Johnson position peaked at $2.55M in Q2 2019.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.